RaNA Therapeutics

RaNA is discovering and developing drugs to improve health for patients by modulating disease-associated long non-coding RNA (lncRNA), thereby restoring normal expression of individual targeted genes. The technology platform is based on thousands of gene-associated lncRNA’s that contain binding regions for epigenetic regulatory proteins.

Headquarters Cambridge, MA
Website www.ranarx.com​
Twitter @RaNA_Tx​
Pipeline Preclinical